Effect of Alpha Lipoid Acid in Diabetic Neuropathy patients
Not Applicable
Completed
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2020/10/028346
- Lead Sponsor
- Dr Kammila Sireesha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
1. Type 2 diabetic patients of either sex aged between 30 - 65 years
2. Symptomatic diabetic polyneuropathy patients with VPT value more than 15V
3. HbA1c < 10%,
4. Patients on stable dose of antidiabetic drug or combination of Metformin + sulphonyl urea + DPP4 Inhibitors for the past 3 months
5. Patients on stable dose of Gabapentin 300 mg BD for past 3 months 6. Serum creatinine < 2 mg/dl.
Exclusion Criteria
1. Any other conditions causing neuropathic pain
2. History of hypersensitivity to alpha Lipoic acid
3. Patients receiving other antioxidants.
4. Patients with active cardiovascular disease
5. Patients with clinically significant skin disease
6. Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method